Jon Feliciano

Left Guard

Age: 31
Free Agency: 2024 (UFA)
Accrued Seasons: 7
  • 2023 Salary Cap Charge: $2,250,000 (0.95% of cap)
  • 2023 Cash Payout: $2,250,000 (0.88% of spending)
  • 2023 Cash to Cap Ratio: 1.00
  • Contract Value: $2,250,000 ($2,250,000 APY)
  • Fully Guaranteed Money: $2,250,000
  • Contract Ranking: 21/95 at LG

Current Contract

(UFA, signed 2023)
(📝: indicates contract trigger occuring during that year)
YearAgeBase SalaryProrated BonusWorkout BonusGuaranteed SalaryCap
Number
Cap %
Dead Money & Cap Savings
202331$1,165,000$1,085,000$85,000$1,165,000$2,250,0001.0%
Total$1,165,000$1,085,000$85,000$1,165,000$2,250,000

Contract Notes

Jon Feliciano signed a three year contract with the Buffalo Bills on March 22, 2021. Contract base value is $14.4 million with $4.4 million guaranteed at signing. Feliciano can earn an additional $1.5 million in vesting guarantees with 5th day the 2022 and 2023 league years. Feliciano can earn additional $2.4 million through performance incentives and another $1.3 million through performance escalators.

Cash Flows

- fully earned money
- unearned or partially earned money
$2.3M
2023
Cash Due$2,250,000
Running Cash$2,250,000
Career Earnings: $14,890,652
Career APY: $2,127,236
Potential Earnings: $16,140,652
Total Guarantees: $13,410,652
Largest Cash Payment: $4,650,000 (2019)
Largest Cap Number: $4,400,000 (2020)

Contract History

TeamContract TypeStatusYear SignedYrsTotalAPYGuaranteesAmount Earned% EarnedEffective APY
RaidersDraftedExpired20154$2,740,652$685,163$460,652$2,740,652100.0%$685,163
BillsUFAExpired20192$7,250,000$3,625,000$3,900,000$7,900,000109.0%$3,950,000
BillsUFATerminated20213$14,400,000$4,800,000$4,400,000$00.0%$0
GiantsSFAExpired20221$3,250,000$3,250,000$2,400,000$3,250,000100.0%$3,250,000
49ersUFAActive20231$2,250,000$2,250,000$2,250,000$1,000,00044.4%$0
Earnings By Team
TeamYrsSalaryAPYPaid on Cap% Paid on CapPaid as Dead Money% Paid as Dead Money
Raiders4$2,740,652$685,163$2,740,6520.0%$00.0%
Bills2$7,900,000$3,950,000$7,900,0000.0%$1,500,0000.0%
Giants1$3,250,000$3,250,000$2,897,0590.0%$00.0%
49ers0$1,000,000$0$00.0%$00.0%

Season History

YearTeamBase SalaryProrated BonusRoster BonusPer Game Roster BonusWorkout BonusOther BonusGuaranteed SalaryCap
Number
Cap %Cash Paid
2015Raiders$435,000$115,163$0$0$0$0$0$550,1630.4%$895,652
2016Raiders$525,000$115,163$0$0$0$0$0$640,1630.4%$525,000
2017Raiders$615,000$115,163$0$0$0$0$0$730,1630.4%$615,000
2018Raiders$705,000$115,163$0$0$0$0$0$820,1630.5%$705,000
2019Bills$2,400,000$750,000$0$250,000$100,000$0$2,400,000$3,500,0001.8%$4,650,000
2020Bills$2,650,000$750,000$250,000$250,000$100,000$400,000$250,000$4,400,0002.0%$3,250,000
2022Giants$1,150,000$1,250,000$0$750,000$100,000$0$1,150,000$2,897,0591.4%$3,250,000
202349ers$1,165,000$1,085,000$0$0$85,000$0$1,165,000$2,250,0001.0%$2,250,000
Total$9,645,000$4,295,652$250,000$1,250,000$385,000$400,000$4,965,000$15,787,711$16,140,652
Dead Money History
TeamYearCap ChargeCash Paid
Bills2022$1,500,000$0
Total$1,500,000$0

Statistics

YearGames PlayedGames InactiveSnaps
InjuredHealthyOffenseSpecial
201560817.8%4.4%
201616003.4%28.7%
2017132112.2%25.1%
2018133021.6%12.9%
2019160088.9%13.6%
202090052.5%4.3%
202190136.9%3.0%
2022150185.7%0.0%

Valuation Diamond

The diamond is a scatterplot graph that visualizes the relation of the player's APY (in green) and performance (in blue, as measured by OTC's Valuations) to the rest of the league at his position. To understand how to read the diamond, read this explainer.

OTC ValuationAPY
Regular$3,799,000$2,250,000
Injury Adjusted$3,799,000$2,250,000
test
OTC Valuation $1.9M $3.8M $5.8M $7.7M $9.6M APY $3.3M $6.7M $10M $13.3M $16.7M $5,999,000 $3,988,352

Weekly Valuation Trends

The chart below illustrates the trend of the player's weekly OTC Valuations (in blue) from the most recent season, using APY (in green) and, if applicable, cash that is due to the player in the next season (in red) as benchmarks. Weeks not plotted indicate that the player was inactive or on a bye.

To see interactive and more in-depth use of OTC Valuation data, subscribe to OTC Premium.